Search Results

Pharm Country

Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital

Helius Medical Technologies, Inc. today announced the expansion of the registrational program with the addition of Brooks Rehabilitation Hospital (“Brooks Rehabilitation”).

January 11, 2024

·

8 min read

Pharm Country

Brooke Eby, ALS Patient and Advocate, to deliver Keynote Address at 2024 MDA Clinical & Scientific Conference

The Muscular Dystrophy Association announced Brooke Eby will be the keynote speaker at the 2024 MDA Clinical & Scientific Conference, where she will address the world’s leaders in neuromuscular disease research and care.

February 15, 2024

·

3 min read

Business

Empress Therapeutics Appoints Virginia Finnerty-Brooks Chief Business Officer

Empress Therapeutics today announced that Virginia Finnerty-Brooks has been appointed Chief Business Officer (CBO).

December 6, 2023

·

3 min read

Entrance to the U.S. Department of Health and Human Services in Washington, DC

Drug pricing

More Than Half of IRA Negotiation Savings to Come From Three Drugs: Report

Amgen’s Enbrel, Bristol Myers Squibb’s Eliquis and Johnson & Johnson’s Stelara will account for 51.4% of the Inflation Reduction Act’s drug price negotiation savings in 2026, according to the Brookings Institution.

August 20, 2024

·

2 min read

·

Tristan Manalac

Stony Brook Study on the Role of DNA Amplification in Cancer Chemoresistance Leverages KromaTiD dGH in-Site™ Technology

A Stony Brook University team of researchers led by Gábor Balázsi , PhD, has identified DNA amplification as a major cause of drug resistance in engineered mammalian cell lines and has identified a novel approach to overcome it in those cells as well as in two human cancer cell lines.

February 6, 2024

·

2 min read

Business

Solid Biosciences Appoints Gabriel Brooks, M.D., as Chief Medical Officer

Solid Biosciences Inc. today announced the appointment of Gabriel Brooks, M.D., as Chief Medical Officer.

October 2, 2023

·

5 min read

Immutep successfully completes institutional placement and institutional component of entitlement offer

Immutep Limited ACN 009 237 889 is pleased to announce the successful completion of its institutional placement and the institutional component of its 1 for 16 pro rata accelerated non-renounceable entitlement offer of new fully paid ordinary shares in Immutep.

June 5, 2024

·

7 min read

Press Releases

Ellison Institute of Technology Los Angeles Accelerates Cancer Research with Sapio LIMS

October 23, 2024

·

3 min read

BioForest

Pacific Northwest Research Institute Uncovers Hidden DNA Mechanisms of Rare Genetic Diseases

Researchers at the Pacific Northwest Research Institute (PNRI) and collaborating institutions have made a groundbreaking discovery that could significantly advance our understanding of genomic disorders.

June 21, 2024

·

3 min read

Business

The Foundation for the National Institutes of Health Names Recipients of the 2024 Charles A. Sanders, MD, Partnership Award

The Foundation for the National Institutes of Health will award the 2024 Charles A. Sanders, MD, Partnership Award to the National Institutes of Health’s National Institute of Neurological Disorders and Stroke, AbbVie, and Robert and Sarah Newcomb.

June 18, 2024

·

4 min read